There is a clear need for better measures against both natural and man-made emerging epidemic threats. Our FluForecast™ product leverages the core Replikins technology to help identify rises in peptide quantities which precede observed epidemics by one to two years. Further, after an epidemic runs its course there is a decline in those quantities.
The United Nations FAO, among others, has identified the promise of this technology in driving appropriate public health measures, and in getting an early start on targeted vaccine development. Replikins believes that it can provide a clear competitive advantage to companies and governments in this area.